(15009138), K. S. R., (22687839), J. S. L., (15352499), M. M. M., (14850778), C. U. B., (22687842), I. R., (22687845), F. T., . . . (15027870), I. V. (2025). Figure S3 from Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.
Dyfyniad Arddull Chicago(15009138), Kristoffer Staal Rohrberg, et al. Figure S3 from Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors. 2025.
Dyfyniad MLA(15009138), Kristoffer Staal Rohrberg, et al. Figure S3 from Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors. 2025.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.